COVID-19, Hormones and Brain

With the COVID-19 pandemic not yet over several links are emerging concerning the brain reactivity and the severity of the SARS-CoV2 infection. The brain as target of the long COVID symptomatology seems one of the most evident sequelae among the survivors. On the other hands, the gender seems to influence the severity of the SARS-CoV2 infection, with higher protection in males during the early phases of the inflammatory reaction but with higher mortality in male patients over the longer time. This collection of updated reviews on the theme COVID-19, hormones and brain, adds important contributions to such progressing and complex interplay.

•  
  Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage?: Neuroendocrine immunology of vitamin D in SARS-CoV-2 infection
  Emanuele Gotelli; Stefano Soldano; Elvis Hysa; Andrea Casabella; Andrea Cere; Carmen Pizzorni; Sabrina Paolino; Alberto Sulli; Vanessa Smith; Maurizio Cutolo
  Neuroimmunomodulation (2023) 30 (1): 185–195 (DOI:10.1159/000533286)

   

•  
  The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
  Larissa Joaquim; Amanda Della Giustina; Richard Simon Machado; Kiuanne Lino Lobo Metzker; Sandra Bonfante; Lucineia Gainski Danielski; Mariana Pereira de Souza Goldim; Fabricia Petronilho
  Neuroimmunomodulation (2022) 29 (4): 269–281 (DOI:10.1159/000526653)

   

•  
  Therapeutic Benefits of Melatonin Against COVID-19
  Muhammad Mubashshir; Nabeel Ahmad; Tripti Negi; Renu Rawal; Nirjara Singhvi; Hina Khatoon; Vijya Laxmi; Om Dubey; Renu Bala Sharma; Ganga Negi; Mohd Ovais
  Neuroimmunomodulation (2023) 30 (1): 196–205 (DOI:10.1159/000531550)

   

Connect with Us

Contact Us

If you have any questions, just get in touch with the Editorial Office